Venetoclax with decitabine or azacitidine in previously untreated TP53mut acute myeloid leukemia. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results